Literature DB >> 24058217

A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones.

Lourdes Castañeda1, Zoë V F Wright, Cristina Marculescu, Trang M Tran, Vijay Chudasama, Antoine Maruani, Elizabeth A Hull, João P M Nunes, Richard J Fitzmaurice, Mark E B Smith, Lyn H Jones, Stephen Caddick, James R Baker.   

Abstract

Bromomaleimides are useful building blocks in synthesis and powerful reagents for the selective chemical modification of proteins. A mild new synthesis of these reagents is described, along with the convenient transferability of the approach to dithiomaleimides and bromopyridazinediones.

Entities:  

Keywords:  Bromomaleimides; Pyridazinediones; Reagent synthesis; Reagents for cysteine modification; Thiomaleimides

Year:  2013        PMID: 24058217      PMCID: PMC3776223          DOI: 10.1016/j.tetlet.2013.04.088

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


Bromomaleimides 1 are useful building blocks for synthesis, undergoing a diverse range of reactions including nucleophilic addition and cross-coupling. For example, dibromomaleimides have been used extensively as starting materials for the synthesis of bisaryl maleimides, as inhibitors of protein kinase C. Bromomaleimides have also been demonstrated as powerful reagents for the selective chemical modification of cysteine residues in peptides and proteins. In this context, bromomaleimides represent the parent members of a larger class of reagents for use in bioconjugation. Varying the leaving groups on the 3 and 4 positions of the maleimide allows fine-tuning of the properties of the reagent. Notably, exchanging the bromines with thiophenols affords reagents which can be employed in the in situ bridging of disulfide bonds and are tolerant to incorporation into polymers. The six-membered ring analogues, bromopyridazinediones 2, offer a similar and yet distinct reactivity profile for cysteine conjugation. Bromomaleimides 1 and bromopyridazinediones 2 are commonly synthesised by treating a bromomaleic anhydride 3 with an amine or hydrazine respectively and heating at reflux in AcOH to carry out the dehydrative cyclisation (Scheme 1). These conditions are extremely harsh, and are not suitable if the amine or hydrazine contains sensitive functionality. Furthermore, to access the dithiophenolmaleimides a subsequent step is required involving the treatment of the dibromomaleimide with thiophenol and a base.
Scheme 1

The current synthesis of bromomaleimides 1 and bromopyridazinediones 2.

The reaction of amines with N-methoxycarbonylmaleimide (5, X and Y = H) has been reported as a mild approach to synthesise maleimides. We report herein on our efforts towards transferring this chemistry to provide a mild and general synthesis of bromomaleimides, dithiophenolmaleimides and bromo-pyridazinediones. Treatment of dibromo-, monobromo- and dithiophenol-maleimides with methyl chloroformate and N-methylmorpholine (NMM) afforded the corresponding N-methoxycarbonyl activated species 5 in excellent yields (Table 1).
Table 1

Synthesis of N-methoxycarbonylmaleimides

EntryXYYield (%)
1BrBr97
2BrH100
3SPhSPh97
Stirring N-methoxycarbonyldibromomaleimide (6) with a range of amines at room temperature successfully afforded dibromomaleimides 7 in good yields (Table 2, entries 1–15). This represents an extremely mild synthesis, and is effective for alkyl and aryl amines. It should be noted that aniline itself led to a lower yield (entry 11), due to an undetermined competing degradation pathway, but this could be precluded by substitution in the para position of the aniline (entries 12 and 13). Notable examples include: dibromomaleimide–alkyne (entry 3) and dibromomaleimide–azide (entry 6), useful as heterobifunctional cross-linkers, bis-dibromomaleimide (entry 4) as a homobifunctional cross-linker, and dibromomaleimide–aryl fluorides for prospective PET imaging applications (entries 10, 14 and 15). In an analogous fashion N-methoxycarbonylbromomaleimide (8) underwent effective reaction with a number of amines to form monobromomaleimides 9 in moderate yields (entries 16–20). It should be noted that the products in all these reactions are reactive conjugate acceptors, and thus no more than a stoichiometric equivalent of amine should be employed otherwise bis-addition products are observed.
Table 2

A mild synthesis of dibromomaleimides

EntryXRYield (%)
1Br79
2Br79
3Br82
4Br70a
5Br69
6Br80
7Br60
8Br78
9Br86
10Br72
11Br19
12Br78
13Br99
14Br64
15Br46
16H74
17H62
18H58
19H44
20H63

0.4 equiv of diamine used.

The dithiophenolmaleimide variants proved more challenging, and required subtle tuning of the reaction conditions. Addition of amines to activated maleimide 10 led to initial attack to form the acyclic ring-opened intermediates (i.e., cyclisation with release of methyl carbamate was not observed). Upon column chromatography of these intermediates, some cyclisation was observed, implying that the mildly acidic conditions provided by the silica could facilitate the cyclisation. Thus silica was added as a second step in the reaction, and this served to afford the desired dithiophenolmaleimides 11 (Table 3). For simple alkyl amines and benzylamine the yields in this reaction were still disappointing (entries 5–7). In these examples, it was found that the addition of Et3N (1 equiv) at the start of the reaction improved the yield significantly. It could be postulated that the triethylamine was important to prevent protonation, and thus deactivation, of these more basic alkyl amines during the reaction.
Table 3

A mild synthesis of dithiophenolmaleimides

EntryAmineYield (%)
198
283
386
445
542 (66)a
630 (75)a
715 (59)a

Yields in parenthesis indicate the outcome of the reaction when 1 equiv of Et3N was added at the start of the reaction.

Finally, we attempted to transfer this approach to the synthesis of bromopyridazinediones. Thus treatment of activated dibromo- and monobromomaleimides 6 and 8 with N,N′-diethylhydrazine was carried out. Simply stirring the reagents in CH2Cl2 at room temperature led to the desired dibromopyridazinedione 12 and monobromopyridazinedione 13 in moderate yields (Scheme 2).
Scheme 2

A mild synthesis of bromopyridazinediones.

In conclusion, we have shown that bromomaleimides, dithiophenolmaleimides and bromopyridazinediones can all be accessed by the addition of amines to the appropriate N-methoxycarbonyl activated maleimides. The employed methods are extremely mild and provide a general route to this important class of reagents.
  17 in total

1.  Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling. synthesis of multivalent HIV-1 gp41 peptides.

Authors:  Lai-Xi Wang; Jiahong Ni; Suddham Singh
Journal:  Bioorg Med Chem       Date:  2003-01-02       Impact factor: 3.641

2.  [2+2] photocycloadditions of thiomaleimides.

Authors:  Lauren M Tedaldi; Abil E Aliev; James R Baker
Journal:  Chem Commun (Camb)       Date:  2012-04-04       Impact factor: 6.222

3.  Polymeric dibromomaleimides as extremely efficient disulfide bridging bioconjugation and pegylation agents.

Authors:  Mathew W Jones; Rachel A Strickland; Felix F Schumacher; Stephen Caddick; James R Baker; Matthew I Gibson; David M Haddleton
Journal:  J Am Chem Soc       Date:  2012-01-13       Impact factor: 15.419

4.  Development of methods for the synthesis of libraries of substituted maleimides and α,β-unsaturated-γ-butyrolactams.

Authors:  Emelia Awuah; Alfredo Capretta
Journal:  J Org Chem       Date:  2011-03-25       Impact factor: 4.354

5.  Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.

Authors:  Christelle Marminon; Alain Pierré; Bruno Pfeiffer; Valérie Pérez; Stéphane Léonce; Alexandra Joubert; Christian Bailly; Pierre Renard; John Hickman; Michelle Prudhomme
Journal:  J Med Chem       Date:  2003-02-13       Impact factor: 7.446

6.  Bromomaleimides: new reagents for the selective and reversible modification of cysteine.

Authors:  Lauren M Tedaldi; Mark E B Smith; Ramiz I Nathani; James R Baker
Journal:  Chem Commun (Camb)       Date:  2009-09-16       Impact factor: 6.222

7.  Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis.

Authors:  Chris P Ryan; Mark E B Smith; Felix F Schumacher; Dina Grohmann; Danai Papaioannou; Gabriel Waksman; Finn Werner; James R Baker; Stephen Caddick
Journal:  Chem Commun (Camb)       Date:  2011-04-05       Impact factor: 6.222

8.  Protein modification, bioconjugation, and disulfide bridging using bromomaleimides.

Authors:  Mark E B Smith; Felix F Schumacher; Chris P Ryan; Lauren M Tedaldi; Danai Papaioannou; Gabriel Waksman; Stephen Caddick; James R Baker
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

9.  Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'.

Authors:  Felix F Schumacher; Vishal A Sanchania; Berend Tolner; Zoë V F Wright; Chris P Ryan; Mark E B Smith; John M Ward; Stephen Caddick; Christopher W M Kay; Gabriel Aeppli; Kerry A Chester; James R Baker
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Reversible protein affinity-labelling using bromomaleimide-based reagents.

Authors:  Ramiz I Nathani; Vijay Chudasama; Chris P Ryan; Paul R Moody; Rachel E Morgan; Richard J Fitzmaurice; Mark E B Smith; James R Baker; Stephen Caddick
Journal:  Org Biomol Chem       Date:  2013-03-05       Impact factor: 3.876

View more
  11 in total

1.  Making Conjugation-induced Fluorescent PEGylated Virus-like Particles by Dibromomaleimide-disulfide Chemistry.

Authors:  Zhuo Chen; Stacey T Detvo; Elizabeth Pham; Jeremiah J Gassensmith
Journal:  J Vis Exp       Date:  2018-05-27       Impact factor: 1.355

2.  Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides.

Authors:  Magdolna Csávás; Adrienn Miskovics; Zsolt Szűcs; Erzsébet Rőth; Zsolt L Nagy; Ilona Bereczki; Mihály Herczeg; Gyula Batta; Éva Nemes-Nikodém; Eszter Ostorházi; Ferenc Rozgonyi; Anikó Borbás; Pál Herczegh
Journal:  J Antibiot (Tokyo)       Date:  2015-04-01       Impact factor: 2.649

3.  Aminomaleimide fluorophores: a simple functional group with bright, solvent dependent emission.

Authors:  Anne B Mabire; Mathew P Robin; Wen-Dong Quan; Helen Willcock; Vasilios G Stavros; Rachel K O'Reilly
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

4.  Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones.

Authors:  Calise Bahou; Daniel A Richards; Antoine Maruani; Elizabeth A Love; Faiza Javaid; Stephen Caddick; James R Baker; Vijay Chudasama
Journal:  Org Biomol Chem       Date:  2018-02-21       Impact factor: 3.876

5.  Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.

Authors:  Zsolt Szűcs; Viktor Kelemen; Son Le Thai; Magdolna Csávás; Erzsébet Rőth; Gyula Batta; Annelies Stevaert; Evelien Vanderlinden; Lieve Naesens; Pál Herczegh; Anikó Borbás
Journal:  Eur J Med Chem       Date:  2018-08-22       Impact factor: 6.514

6.  Iodine-124 Based Dual Positron Emission Tomography and Fluorescent Labeling Reagents for In Vivo Cell Tracking.

Authors:  Truc Thuy Pham; Zhi Lu; Christopher Davis; Chun Li; Fangfang Sun; John Maher; Ran Yan
Journal:  Bioconjug Chem       Date:  2020-03-11       Impact factor: 4.774

7.  In Vitro Characterization and Stability Profiles of Antibody-Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation.

Authors:  Camille Martin; Guillaume Brachet; Cyril Colas; Emilie Allard-Vannier; Claire Kizlik-Masson; Clara Esnault; Renaud Respaud; Caroline Denevault-Sabourin; Igor Chourpa; Valérie Gouilleux-Gruart; Marie-Claude Viaud-Massuard; Nicolas Joubert
Journal:  Pharmaceuticals (Basel)       Date:  2019-12-02

8.  Homogeneous bispecifics by disulfide bridging.

Authors:  Elizabeth A Hull; Maria Livanos; Enrique Miranda; Mark E B Smith; Kerry A Chester; James R Baker
Journal:  Bioconjug Chem       Date:  2014-08-01       Impact factor: 4.774

9.  Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation.

Authors:  Lourdes Castañeda; Antoine Maruani; Felix F Schumacher; Enrique Miranda; Vijay Chudasama; Kerry A Chester; James R Baker; Mark E B Smith; Stephen Caddick
Journal:  Chem Commun (Camb)       Date:  2013-09-25       Impact factor: 6.222

10.  Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging.

Authors:  Felix F Schumacher; João P M Nunes; Antoine Maruani; Vijay Chudasama; Mark E B Smith; Kerry A Chester; James R Baker; Stephen Caddick
Journal:  Org Biomol Chem       Date:  2014-10-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.